
### [MONDO:0018975](http://purl.obolibrary.org/obo/MONDO_0018975)
**Label:** neurofibromatosis

**Subclasses:** [MONDO:0014299](http://purl.obolibrary.org/obo/MONDO_0014299) (Schwannomatosis 2), [MONDO:0008075](http://purl.obolibrary.org/obo/MONDO_0008075) (neurofibromatosis type 3), [MONDO:0007039](http://purl.obolibrary.org/obo/MONDO_0007039) (neurofibromatosis type 2), [MONDO:0008077](http://purl.obolibrary.org/obo/MONDO_0008077) (neurofibromatosis, type 1), [MONDO:0008078](http://purl.obolibrary.org/obo/MONDO_0008078) (neurofibromatosis, familial spinal), [MONDO:0015350](http://purl.obolibrary.org/obo/MONDO_0015350) (17q11.2 microduplication syndrome), [MONDO:0013357](http://purl.obolibrary.org/obo/MONDO_0013357) (chromosome 17q11.2 deletion syndrome, 1.4Mb), [MONDO:0008080](http://purl.obolibrary.org/obo/MONDO_0008080) (neurofibromatosis, type Iii, mixed central and peripheral), [MONDO:0008081](http://purl.obolibrary.org/obo/MONDO_0008081) (neurofibromatosis, type Iv, of riccardi), [MONDO:0018208](http://purl.obolibrary.org/obo/MONDO_0018208) (neurofibromatosis type 1 due to NF1 mutation or intragenic deletion), 

**Corr. equiv. classes:** [OMIM:162200](http://purl.obolibrary.org/obo/OMIM_162200), [OMIM:162210](http://purl.obolibrary.org/obo/OMIM_162210), [Orphanet:363700](http://www.orpha.net/ORDO/Orphanet_363700), [OMIM:162260](http://purl.obolibrary.org/obo/OMIM_162260), [OMIM:162270](http://purl.obolibrary.org/obo/OMIM_162270), [Orphanet:139474](http://www.orpha.net/ORDO/Orphanet_139474), [OMIM:162091](http://purl.obolibrary.org/obo/OMIM_162091), [OMIM:615670](http://purl.obolibrary.org/obo/OMIM_615670), [Orphanet:93921](http://www.orpha.net/ORDO/Orphanet_93921), [OMIM:613675](http://purl.obolibrary.org/obo/OMIM_613675), [Orphanet:97685](http://www.orpha.net/ORDO/Orphanet_97685), [Orphanet:637](http://www.orpha.net/ORDO/Orphanet_637), [OMIM:101000](http://purl.obolibrary.org/obo/OMIM_101000), 

**Class expressions from DL-Learner:**

- [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) 63.90%
- [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) 63.90%
- [HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) 63.90%
- [HP:0000152](http://purl.obolibrary.org/obo/HP_0000152) (Abnormality of head or neck) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) 63.90%
- [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) and [HP:0100006](http://purl.obolibrary.org/obo/HP_0100006) (Neoplasm of the central nervous system) 61.49%
- [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) 61.49%
- [HP:0000957](http://purl.obolibrary.org/obo/HP_0000957) (Cafe-au-lait spot) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0100006](http://purl.obolibrary.org/obo/HP_0100006) (Neoplasm of the central nervous system) 61.49%
- [HP:0000957](http://purl.obolibrary.org/obo/HP_0000957) (Cafe-au-lait spot) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) 61.49%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0100012](http://purl.obolibrary.org/obo/HP_0100012) (Neoplasm of the eye) 61.49%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0030670](http://purl.obolibrary.org/obo/HP_0030670) (Hamartoma of the orbital region) 61.49%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0010568](http://purl.obolibrary.org/obo/HP_0010568) (Hamartoma of the eye) 61.49%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) 61.49%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0100012](http://purl.obolibrary.org/obo/HP_0100012) (Neoplasm of the eye) 61.49%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0030670](http://purl.obolibrary.org/obo/HP_0030670) (Hamartoma of the orbital region) 61.49%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0010568](http://purl.obolibrary.org/obo/HP_0010568) (Hamartoma of the eye) 61.49%


